Nano-X Imaging (NNOX) to Release Quarterly Earnings on Wednesday

Nano-X Imaging (NASDAQ:NNOX) is expected to announce its Q2 2026 results before the market opens on Wednesday, September 9th. Analysts expect the company to announce earnings of ($0.1620) per share and revenue of $5.3760 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, September 9, 2026 at 8:30 AM ET.

Nano-X Imaging (NASDAQ:NNOX) last posted its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) earnings per share (EPS) for the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. The firm had revenue of $4.31 million during the quarter. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Nano-X Imaging Stock Performance

NNOX opened at $0.83 on Tuesday. The stock’s 50-day moving average price is $1.00 and its 200 day moving average price is $1.70. Nano-X Imaging has a 12-month low of $0.71 and a 12-month high of $4.71. The firm has a market cap of $65.21 million, a price-to-earnings ratio of -0.53 and a beta of 1.26.

Insider Transactions at Nano-X Imaging

In other news, Director Dan S. Suesskind bought 50,000 shares of the business’s stock in a transaction that occurred on Monday, July 27th. The shares were purchased at an average cost of $0.93 per share, for a total transaction of $46,500.00. Following the completion of the purchase, the director owned 50,000 shares of the company’s stock, valued at approximately $46,500. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Erez Meltzer bought 36,000 shares of Nano-X Imaging stock in a transaction that occurred on Monday, July 27th. The stock was purchased at an average cost of $0.93 per share, for a total transaction of $33,480.00. Following the acquisition, the chief executive officer owned 36,000 shares of the company’s stock, valued at $33,480. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders have bought 95,443 shares of company stock valued at $89,706.

Institutional Investors Weigh In On Nano-X Imaging

Several institutional investors have recently modified their holdings of NNOX. AQR Capital Management LLC acquired a new position in shares of Nano-X Imaging during the first quarter worth $178,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Nano-X Imaging by 232.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company’s stock valued at $10,793,000 after buying an additional 1,510,806 shares during the last quarter. Geode Capital Management LLC raised its stake in Nano-X Imaging by 17.5% in the second quarter. Geode Capital Management LLC now owns 810,322 shares of the company’s stock valued at $4,189,000 after buying an additional 120,460 shares in the last quarter. Cetera Investment Advisers lifted its holdings in Nano-X Imaging by 82.0% during the 2nd quarter. Cetera Investment Advisers now owns 48,056 shares of the company’s stock worth $248,000 after buying an additional 21,657 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Nano-X Imaging by 61.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 65,783 shares of the company’s stock worth $340,000 after buying an additional 25,048 shares during the last quarter. 21.49% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a research note on Wednesday, July 8th. Alliance Global Partners lowered shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $5.00 to $3.00 in a research note on Tuesday, July 7th. Zacks Research raised shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $5.00 target price on shares of Nano-X Imaging in a report on Monday, August 17th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $4.33.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.